About Adherium

Adherium is a global leader in the design and development of evidence-based digital health solutions. We have more than 14 years’ experience developing and supplying innovative patient management systems.

Our smart health solutions use connected devices, software and data to improve the quality of care — and quality of life — for those with asthma, COPD and other chronic diseases.

READ MORE

SMARTINHALER

Adherium’s proprietary platform comprising medical devices, apps and cloud-based management software for use in chronic respiratory disease is called Smartinhaler™.

Through a comprehensive body of peer-reviewed research, the Smartinhaler™ platform has been independently proven to improve medication adherence and health outcomes in adults and children.

Devices in the Smartinhaler™ product range have European CE marking, US FDA 510(k) clearances to market, as well as Australian TGA and New Zealand MedSafe approvals.

READ MORE

Investors

Adherium is a fast growth digital health company, focused on designing, developing and manufacturing end to end digital health solutions which improve patient management and health outcomes in chronic disease.

Adherium (ASX.ADR) listed on the Australian Stock Exchange (ASX) in August 2015.

READ MORE

Contact

Level 2

204 Quay Street

Auckland 1010

New Zealand

PO Box 106612

Auckland 1143

New Zealand

Level 14

140 William Street

Melbourne

Vic 3000

Australia

For all enquiries please email

info@adherium.com